149 related articles for article (PubMed ID: 11915940)
1. The murine complement regulator Crry: new insights into the immunobiology of complement regulation.
Molina H
Cell Mol Life Sci; 2002 Feb; 59(2):220-9. PubMed ID: 11915940
[TBL] [Abstract][Full Text] [Related]
2. A critical role for murine complement regulator crry in fetomaternal tolerance.
Xu C; Mao D; Holers VM; Palanca B; Cheng AM; Molina H
Science; 2000 Jan; 287(5452):498-501. PubMed ID: 10642554
[TBL] [Abstract][Full Text] [Related]
3. Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicity.
Caragine TA; Imai M; Frey AB; Tomlinson S
Blood; 2002 Nov; 100(9):3304-10. PubMed ID: 12384431
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.
Miao J; Lesher AM; Miwa T; Sato S; Gullipalli D; Song WC
Kidney Int; 2014 Oct; 86(4):726-37. PubMed ID: 24850152
[TBL] [Abstract][Full Text] [Related]
5. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.
Molina H; Miwa T; Zhou L; Hilliard B; Mastellos D; Maldonado MA; Lambris JD; Song WC
Blood; 2002 Dec; 100(13):4544-9. PubMed ID: 12393518
[TBL] [Abstract][Full Text] [Related]
6. Modulation of protective T cell immunity by complement inhibitor expression on tumor cells.
Varela JC; Imai M; Atkinson C; Ohta R; Rapisardo M; Tomlinson S
Cancer Res; 2008 Aug; 68(16):6734-42. PubMed ID: 18701498
[TBL] [Abstract][Full Text] [Related]
7. Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack.
Barata L; Miwa T; Sato S; Kim D; Mohammed I; Song WC
J Immunol; 2013 Mar; 190(6):2886-95. PubMed ID: 23390291
[TBL] [Abstract][Full Text] [Related]
8. Membrane protein Crry maintains homeostasis of the complement system.
Wu X; Spitzer D; Mao D; Peng SL; Molina H; Atkinson JP
J Immunol; 2008 Aug; 181(4):2732-40. PubMed ID: 18684964
[TBL] [Abstract][Full Text] [Related]
9. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
Miwa T; Zhou L; Hilliard B; Molina H; Song WC
Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
[TBL] [Abstract][Full Text] [Related]
10. Complement-dependent T-cell lymphopenia caused by thymocyte deletion of the membrane complement regulator Crry.
Miwa T; Zhou L; Kimura Y; Kim D; Bhandoola A; Song WC
Blood; 2009 Mar; 113(12):2684-94. PubMed ID: 19136662
[TBL] [Abstract][Full Text] [Related]
11. Expression of a soluble complement inhibitor protects transgenic mice from antibody-induced acute renal failure.
Schiller B; Cunningham PN; Alexander JJ; Bao L; Holers VM; Quigg RJ
J Am Soc Nephrol; 2001 Jan; 12(1):71-79. PubMed ID: 11134252
[TBL] [Abstract][Full Text] [Related]
12. Increased serum C3 levels in Crry transgenic mice partially abrogates its complement inhibitory effects.
Kang HJ; Bao L; Xu Y; Quigg RJ; Giclas PC; Holers VM
Clin Exp Immunol; 2004 May; 136(2):194-9. PubMed ID: 15086380
[TBL] [Abstract][Full Text] [Related]
13. Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury.
Quigg RJ; He C; Lim A; Berthiaume D; Alexander JJ; Kraus D; Holers VM
J Exp Med; 1998 Oct; 188(7):1321-31. PubMed ID: 9763611
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis.
Mühlfeld AS; Segerer S; Hudkins K; Farr AG; Bao L; Kraus D; Holers VM; Quigg RJ; Alpers CE
Kidney Int; 2004 Apr; 65(4):1214-23. PubMed ID: 15086460
[TBL] [Abstract][Full Text] [Related]
15. Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure.
Bao L; Wang Y; Chang A; Minto AW; Zhou J; Kang H; Haas M; Quigg RJ
J Am Soc Nephrol; 2007 Mar; 18(3):811-22. PubMed ID: 17229915
[TBL] [Abstract][Full Text] [Related]
16. Complement regulation during pregnancy.
Molina H
Immunol Res; 2005; 32(1-3):187-92. PubMed ID: 16106069
[TBL] [Abstract][Full Text] [Related]
17. Complement inhibitor Crry expression in mouse placenta is essential for maintaining normal blood pressure and fetal growth.
Banadakoppa M; Pennington K; Balakrishnan M; Yallampalli C
PLoS One; 2020; 15(8):e0236968. PubMed ID: 32745140
[TBL] [Abstract][Full Text] [Related]
18. Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells.
Fernández-Centeno E; de Ojeda G; Rojo JM; Portolés P
J Immunol; 2000 May; 164(9):4533-42. PubMed ID: 10779754
[TBL] [Abstract][Full Text] [Related]
19. Mesangial cell complement receptor 1-related protein y limits complement-dependent neutrophil accumulation in immune complex glomerulonephritis.
Bao L; Wang Y; Chen P; Sarav M; Haas M; Minto AW; Petkova M; Quigg RJ
Immunology; 2009 Sep; 128(1 Suppl):e895-904. PubMed ID: 19740350
[TBL] [Abstract][Full Text] [Related]
20. The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells.
Renner B; Coleman K; Goldberg R; Amura C; Holland-Neidermyer A; Pierce K; Orth HN; Molina H; Ferreira VP; Cortes C; Pangburn MK; Holers VM; Thurman JM
J Immunol; 2010 Sep; 185(5):3086-94. PubMed ID: 20675597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
